Eszopiclone did not maximize tumors inside of a p53 transgenic mouse bioassay at oral doses around 300 mg/kg/day. Mutagenesis Eszopiclone was clastogenic in in vitro (mouse lymphoma and chromosomal aberration) assays in mammalian cells. Eszopiclone was damaging in the in vitro bacterial gene mutation (Ames) assay As well as in https://erwinn653zoc0.vidublog.com/profile